tissue patch 3 information for distributors v1
TRANSCRIPT
Information for Distributors
Background to Tissuemed
• Tissuemed is a prominent medical device company based in Leeds, UK
• Founded by surgeons as a University spin-out (mid-1970’s)
• Initially focused on tissue heart valves and grafts
• Current R&D focus is on:– Tissue Sealants / Contact Adhesives / Local Delivery
A few definitions of words you will see:
Haemostasis: Literally “static (still) blood”….slowing blood flow down will result in it clotting (flow rate?). Haemostat….something that stops blood flow.
Thrombogenic: Literally “clot-generating”…..so a thrombogenic haemostat works by biochemically inducing a clotting reaction. Thrombogenic materials are typically proteinaceous (collagen/fibrin). Importantly Tissuepatch3 is NOT a thrombogenic haemostat…..it only induces clotting by virtue of its barrier effect which slows blood flow to levels at which it will clot, which is why it is only indicated for mild to moderate bleeds.
Covalent: Interaction between molecules resulting in a strong physical bond.
Electrostatic: Lower level bonding between atoms carrying opposite charges.
Autologous: Derived or transferred from the same individual’s body
Multilaminate: Many layered
The Product –Tissuepatch3
What is Tissuepatch3 ?
Tissuepatch3
is a sealant and barrier film for the adjunctive prevention of air, blood and/or fluid leakage in thoracic and general surgery
Tissuepatch3
is a completely synthetic product. Unlike commonly used sealants and haemostats it does not contain any human or animal derived materials.
What isn’t Tissuepatch3 ?
Tissuepatch3
is not a thrombogenic haemostat. It is not designed to biologically induce clotting and therefore will not stop significant bleeds.
Cross section:
Adhesive, sealant and barrier
properties provided by fused laminate
structure preformed in manufacture
Tissuepatch3 Description
• Thin film (≤40µm), flexible, integrated tissue sealant, barrier and adhesive
• Made from absorbable synthetic materials
• Highly versatile
• Self-adhesive and tissue-bonding
• Dry and ready-to-use
Barrier laminate
Sealant laminate overprinted with brand
Cohesive laminate
Sealant and Adhesive laminate
Product Advantages
Cost-Effective: Reduced OR time, tissue support during wound healing, and reduced hospital stay.
Broad Sealing: Self-adhesive patch that forms a blood/fluid/airtight seal
Strong: Strong adhesion with cross linking in situ.
Flexible/Elastic: Can be applied to non-uniform surfaces.
Easy to Use: “Open and Apply”. No guns, no cartridges, no preparation required,Bonds to surgical site in <30 seconds.
Synthetic: Constructed from synthetic polymers. No human or animal material. Gamma-sterilized. Absorption in about 50 days.
Approvals: CE mark approved
Indication
Tissuepatch3 is indicated for use to seal and reinforce against:
air leakage in thoracic surgery, e.g. lung resection leakage of low pressure or oozing bleeding in general surgery
Tissuepatch3 is intended for use as an adjunct in thoracic and general surgery. It is not intended to replace sutures or staples.
When bleeding or air leak cannot be controlled with conventional methods, Tissuepatch3 can be applied to a wound to seal the area effectively within 30 seconds.
Mechanism of action
Tissuemed’s patented polymer technology enables Tissuepatch3 to bond to a range of tissue surfaces in a two-stage process.
Preclinical efficacy
The preclinical efficacy of Tissuepatch3 has been demonstrated using two surgical models:
• Thoracic
• General
Both show Tissuepatch3 to be an effective treatment for the sealing of air and blood leaks.
Thoracic surgery model
• Porcine lung (n=6)• Punch biopsy to create pleural defect• Acute air leak grading• 14 and 28 day recovery
Thoracic surgery model
t ≤ 30 minutes t =14 days
General surgery model
• Rabbit liver (n=9)• Punch biopsy to create low rate bleed• Acute blood loss collection• 1, 2 and 4 month recovery
General surgery model
t < 10 minutes t = 2 months
Clinical performance - History
Tissuepatch3 is based on the clinically proven benefits of Tissuepatch2, while offering improved flexibility and conformance to tissue.
Tissuepatch2, has been used clinically by thoracic surgeons. This product, using Tissuemed’s adhesive polymer as a dry powder has been shown to be effective in reducing air leaks.
Clinical performance – Tissuepatch2
Multi-Centre Clinical Investigation to Evaluate the Safety and Performance of Tissuepatch2 in the Prevention of Air Leaks Following Lung Resection
• Target population: Patients undergoing lung resection
• Two centre study with 3 Clinical Investigators
• Patient treatment completed - 17
• Follow-up - 6 weeks, 3 and 6 months
Clinical performance – Tissuepatch2
• Easy to handle and apply
• Immediate and sustained reduction in air leaks
• Normal fluid discharge and patient recovery
• Early removal of chest drain(s) (107 hrs v 125-166 hrs)
• Early hospital patient discharge (6 days v 10-14 days)
• No device related adverse events
• Strong surgeon endorsement
Tissuemed Opinion: Tissuepatch2 has proven efficacy and safety.Tissuepatch3 is expected to maximise already very substantial competitive advantages
Clinical performance – Tissuepatch2
• Tissuepatch2 performs better than Tachosil (Nycomed).
• Tissuepatch3 is expected to offer further improvements
Clinical performance – Tissuepatch3
A Post-Market Surveillance Study of the Safety and Performance of Tissuepatch3 in the Prevention of Air Leaks Following Lung Surgery
• Target population: Patients undergoing lung surgery
• Two centre study with 2 Clinical Investigators
• Patients to be treated - 20
• Follow-up - 6 weeks and 3 months
Comments to Date: “Extremely Good First Impressions”
Company Product Product Type
Selling price*
Source/Material Preparation/Application time
Efficacy(Reason)
Comments
Baxter Tisseel Liquid £200 Human/Animal Preparation Time – 15-20 mins***Application Time – 1-2 mins
Low(Strength) Haemostat action greater than sealant effect
CSL Behring /Nycomed
Beriplast Liquid £200 Human/Animal Preparation Time – 15-20 mins***Application Time – 1-2 mins
Low(Strength) Haemostat action greater than sealant effect
Ethicon/Omrix Quixil/Crosseal
Liquid £200 Human Preparation Time – 15-20 mins***Application Time – 1-2 mins
Low(Strength) Haemostat action greater than sealant effect
CryoLife BioGlue Liquid £190 Animal Preparation Time – 2-3 minsApplication Time – 1-2 mins
Low(Weak adhesion) Cytotoxicity concerns relating to glutaraldehyde component
Nycomed Tachosil /Tachocomb
Sheet £209 Human/Animal Preparation Time – 2-3 mins ** Application Time – 3-5 mins **
Medium(Slow/Weak adhesion) Poor surface-conformance
Thermogenesis CryoSeal Liquid £160 Autologous Preparation Time – 60 mins**Application Time – 1-2 mins**
Low(Strength) Requires processing unit to convert patients blood to product
Vivolution Vivostat Liquid £160 Autologous Preparation Time – 30 mins**Application Time – 1-2 mins**
Low(Strength) As CryoSeal
Confluent Surgical
DuraSeal Liquid £220 Synthetic Preparation Time – 1-2 minsApplication Time – 1-2 mins
Low(Strength,Short duration)
Genzyme FocalSeal Liquid £180 Synthetic Preparation Time – 2-4 mins***Application Time – 5-10 mins
Low(Strength/Short duration) Requires light source
Tissuemed Tissuepatch3 Film £200 Synthetic Preparation Time – 0 minsApplication Time – 30 secs/patch
High (Contact surface chemistry, duration of effect)
Matrix of competitive sealant products used in Lung Surgery
* Equivalent per 5cm x 5cm patch** Company information *** Report entitled Topical Hemostats in Surgery; Mary Jo Drew MD 2003
All liquid sealants require applicators or spray systems…..prices not included as this may be provided Free of ChargeGeneral comment: Unlike Tissuepatch3 none of the listed products, excluding FocalSeal, was originated based on the lung application, which explains their generally low acceptance.
Fibrin-based Liquids(Tisseel, Beriplast, Quixil)
•Typically require “mixing” up to 20 minutes prior to application
•Need time (1-2 minutes) to work
•Have low intrinsic strength
•Require careful application and may be difficult to apply uniformly to target tissue
•Are derived from human/animal sources
•Have a haemostatic rather than adhesive sealant effect
Synthetic Liquids (Duraseal, Focalseal)
•Typically require “mixing” a few(1-2) minutes prior to application
•Need time to apply (Focalseal – 5-10 minutes) and work (1-2 minutes)
•Have low intrinsic strength
•Require careful application and may be difficult to apply uniformly to target tissue
•Have low duration of effect because of their chemistry
•In the case of Focalseal requires a Light source to activate.
Autologous “sealants” (Cryoseal, Vivostat)
•Require extended preparatory process involving blood removal from patient 30-60 minutes prior to application
•Need time (1-2 minutes) to work
•Have low intrinsic strength
•Require careful application and may be difficult to apply uniformly to target tissue
•Have low adhesion, acting primarily as haemostats
•Requires significant hardware
Sheet-type haemostats (Tachosil,Tachocomb)
•Require preparation (2-3minutes)
•Need time (3-5 minutes) to work
•Are derived from human/animal proteins
•Have low adhesion
•Are bulky and have poor “conformability”
Questions and Answers
What is Tissuepatch3?Tissuepatch3 is a self adhesive surgical sealant and barrier. It is a thin flexible film supplied in three sizes; small (25mm × 50mm), medium (50mm × 50mm) and large (50mm × 100mm). Tissuepatch3 is 40 microns (0.04mm) thick.
What procedures is Tissuepatch3 indicated for?Tissuepatch³ is indicated for use to seal and reinforce against air leakage in thoracic surgery, and against leakage of low pressure or oozing bleeding or fluid leakage following surgical procedures on soft tissue. Tissuepatch³ is intended for use as an adjunct in thoracic and general surgery and is not intended to replace sutures or staples, as appropriate, in tissue approximation.
How does Tissuepatch3 work?Upon application Tissuepatch3 immediately adheres to the surface by a combination of electrostatic and covalent bonding.
How adhesive is Tissuepatch3?The adhesive strength of Tissuepatch3 is significantly higher (×100) than that of commonly used haemostats (e.g. Tisseel) and sealants (e.g. CoSeal).
Questions and Answers
Does Tissuepatch3 contain animal/human derived material?No – Tissuepatch3 is entirely synthetic.
What are the storage conditions for Tissuepatch3?Tissuepatch3 should be stored at 2-8C. It should not be frozen. The product currently has a shelf life of 17 months.
How is Tissuepatch3 packaged?For each product size, a single device is packaged within a sterile paper/plastic inner pouch, which is further sheathed in an outer foil pouch the outside of which is NON-STERILE.
Can Tissuepatch3 be cut to shape?Yes – Tissuepatch3 can be cut to shape with sterile scissors. Handling, especially of the contact surface should be minimised and it should be kept dry.
Should Tissuepatch3 be applied dry or wet?Tissuepatch3 should remain dry until applied. Wetting will affect adhesion performance.
Questions and Answers
How should Tissuepatch3 be applied?Before application the site should be wiped to remove excess blood/fluid. With the “TP 3” text readable, pressure should be exerted across the patch using a dry swab for at least 30 seconds.
Can Tissuepatch3 be removed?If Tissuepatch3 has been applied incorrectly or has not adhered it may be removed within the first few minutes of application. The tissue may be prepared for application of a new patch.
How large a patch should I use?During application there should be a 1cm margin between the injury and the edge of the Tissuepatch3 applied. When treating large injuries Tissuepatch3 may be overlaid.
Is there a limit to how many patches can be applied?Preclinical data supports the safe use of up to 8 small (25mm × 50mm × 0.04mm), 4 medium (50mm × 50mm × 0.04mm) and 2 large (50mm × 100mm × 0.04mm) patches.
Questions and Answers
Can Tissuepatch3 be resterilised?No – Tissuepatch3 is a sterile single patient use medical device. Once opened Tissuepatch3 should be kept dry and used within 6 hours, after which it should be discarded.
Can Tissuepatch3 be removed?If Tissuepatch3 has been applied incorrectly or has not adhered it may be removed within the first few minutes of application. The tissue may be prepared for application of a new patch.
Are there any contra-indications for use?Tissuepatch3 should not be used on patients with a known allergy to its constituents. It should not be used to seal defects in neurological applications. It is not for intravascular use.
What is the “TP 3” logo for?Tissuepatch3 should be applied so the “TP 3” logo can be read.
Is Tissuepatch3 biodegradable?Tissuepatch3 remains in position covered in a thin fibrous cover and it slowly degrades until resorbed in 50 days.
In conclusion…..a few soundbites
•Because of its construction and contact surface chemistry Tissuepatch3 is the most effective product available for prevention of air leakage in lung surgery
•Tissuepatch3 requires no advance preparation, mixing, soaking or extended contact apposition…..it requires the least amount of preparation and application time of all available products, being truly “open and apply”
•Tissuepatch3 is the easiest product to handle and apply to the target tissue.